BERKELEY, CA -- (Marketwired) -- 06/09/15 --
Dynavax Technologies Corporation (NASDAQ: DVAX) today announced that Michael Ostrach, the Company's Chief Financial Officer, will present at the William Blair 35th Annual Growth Stock Conference on Thursday, June 11, 2015 at 8:00 AM Central Time at the Four Seasons Hotel in Chicago.
A live webcast of the presentation will be available by visiting the "Investors" section of the Dynavax website or may be reached directly at:
http://wsw.com/webcast/blair49/dvax
About Dynavax
Dynavax, a clinical-stage biopharmaceutical company, uses TLR biology to discover and develop novel vaccines and therapeutics in the areas of infectious and inflammatory diseases and oncology. Dynavax's lead product candidates are HEPLISAV-B™, a Phase 3 investigational adult hepatitis B vaccine, and SD-101, an investigational cancer immunotherapeutic currently in several Phase 1/2 studies. For more information visit
www.dynavax.com.
Contact:
Michael Ostrach
Chief Financial Officer
510-665-7257
Email Contact
Source: Dynavax Technologies
News Provided by Acquire Media